Friday 21 September 2018
Contact US    |    Archive
Businessinsider
1 months ago

The FDA just approved a generic EpiPen, and analysts think it has the potential to upend Mylan s hold on the market (MYL, TEVA)

The FDA on Thursday approved Teva Pharmaceuticals generic version of the drug, dealing a blow to branded EpiPen-maker Mylan. Mylan saw an approximately 63% drop in EpiPen sales between 2017 and 2016, according to calculations ma

Read on the original site


هذه الصفحة هي مجرد قاریء تلقائي للأخبار باستخدام خدمة الـ RSS و بأن نشر هذه الأخبار هنا لاتعني تأییدها علی الإطلاق.
Hashtags:   

The

 | 

FDA

 | 

just

 | 

approved

 | 

generic

 | 

EpiPen

 | 

and

 | 

analysts

 | 

think

 | 

has

 | 

the

 | 

potential

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)